Japan Tissue Engineering Co. Ltd. | Mutual Funds
Mutual Funds that own Japan Tissue Engineering Co. Ltd.
DIAM (Japan) Emerging Market Japanese Equity Fund
84,300
0.21%
-15,700
0.57%
04/17/2017
DIAM (Japan) Emerging Firm Japanese Equity Fund
43,000
0.11%
-1,000
0.17%
05/15/2017
Kokusai Japanese Dream Open Fund
33,699
0.08%
33,699
0.22%
02/26/2018
DIAM (Japan) Hybrid Selection Mother Fund
23,000
0.06%
2,000
0.25%
02/17/2017
Sawakami Asset Management Sawakami Fund
19,999
0.05%
-1
0.01%
08/23/2017
DIAM (Japan) DIAM Emerging Firm Japanese Eq. Open (USD) Type
11,899
0.03%
-28,101
0.08%
09/19/2017
iShares III Plc - MSCI Japan Small Cap UCITS ETF (Inc)
10,400
0.03%
0
0.02%
09/06/2018
CREF Stock Account
8,500
0.02%
0
0%
03/31/2018
SPDR S&P International Small Cap ETF
7,600
0.02%
0
0.01%
09/06/2018
iShares MSCI Japan Small Cap ETF
7,400
0.02%
0
0.03%
09/06/2018
| Address |
6-209-1 Miyakitadori
Gamagori Aichi 443
Japan
|
|
Employees
|
- |
| Website |
http://www.jpte.co.jp |
| Updated |
09/14/2018 |
| Japan Tissue Engineering Co., Ltd. engages in the research, development, and manufacture of cultured biological cells and tissues. It operates through the Regenerative Medicine, Custom Development and Manufacturing, and Research and Development (R&D) Support segments. The Regenerative Medicine segment develops, manufactures, and sells tissue-engineered medical products through autologous culturing techniques. |
